a public good project by the
Synthesis
Company
of California

© 2026

Richard J. Edmondson | doi.page

0 works0 citations0 h-index

Richard J. Edmondson

Manchester Academic Health Science Centre(GB)St Mary's Hospital(GB)St Mary's Hospital(GB)Cancer Research UK Manchester Institute(GB)

Publications by Year

Research Areas

Ovarian cancer diagnosis and treatment, PARP inhibition in cancer therapy, BRCA gene mutations in cancer, Endometrial and Cervical Cancer Treatments, Cancer Genomics and Diagnostics

Most-Cited Works

→ Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer(2015)1,397 cited
→ Molecular Classification of the PORTEC-3 Trial for High-Risk Endometrial Cancer: Impact on Prognosis and Benefit From Adjuvant Therapy(2020)790 cited
→ Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative(2015)481 cited
→ Copy number signatures and mutational processes in ovarian carcinoma(2018)445 cited
→ Engineering microrobots for targeted cancer therapies from a medical perspective(2020)416 cited
→ Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: recurrent disease(2016)293 cited

→ Development of a Functional Assay for Homologous Recombination Status in Primary Cultures of Epithelial Ovarian Tumor and Correlation with Sensitivity to Poly(ADP-Ribose) Polymerase Inhibitors(2010)

267 cited

→ Therapeutic Potential of Poly(ADP-ribose) Polymerase Inhibitor AG014699 in Human Cancers With Mutated or Methylated BRCA1 or BRCA2(2010)258 cited

→ The Manchester International Consensus Group recommendations for the management of gynecological cancers in Lynch syndrome(2019)227 cited

→ Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines(2011)192 cited